Case File №
#VI-2026-0376
HK Fat Cat
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
36 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | X Unrated | 1 | 7.5 | 7.5 | 7.5 | 25 May 2026 |
| 4-Piperidone CAS 41661-47-6 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 27 Feb 2025 |
| 4-Piperidone monohydrate hydrochloride CAS 40064-34-4 | X N/A | 1 | 4.0 | 0.2 | 0.2 | 17 Dec 2024 |
| 5-amino-1MQ | X N/A | 1 | 4.0 | 0.0 | 0.0 | 2 Jul 2025 |
| ACE-031 | X N/A | 1 | 4.0 | 0.8 | 0.8 | 16 Mar 2025 |
| Anadrol Oil | X N/A | 1 | 4.0 | 0.4 | 0.4 | 25 Apr 2025 |
| BAC Water | X N/A | 1 | 4.0 | 0.0 | 0.0 | 17 Dec 2024 |
| Botulinum toxin | X N/A | 1 | 4.0 | 0.0 | 0.0 | 17 Dec 2024 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 4.0 | 0.0 | 0.0 | 28 Mar 2025 |
| Cardiogen | X N/A | 1 | 4.0 | 1.4 | 1.4 | 28 Mar 2025 |
| Chonluten | X N/A | 1 | 4.0 | 0.0 | 0.0 | 27 Feb 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 1 | 4.0 | 1.9 | 1.9 | 7 May 2025 |
| Clenbuterol | X N/A | 1 | 4.0 | 1.4 | 1.4 | 20 Jun 2025 |
| DEPAPD (diethyl phenylacetylpropanedioate) CAS 20320-59-6 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 2 Jul 2025 |
| DSIP | X N/A | 1 | 4.0 | 0.3 | 0.3 | 24 Apr 2025 |
| Dutasteride | X N/A | 1 | 4.0 | 0.0 | 0.0 | 14 Jan 2025 |
| EPO | X N/A | 1 | 4.0 | 0.0 | 0.0 | 13 Feb 2025 |
| GHRP-2 Acetate | X N/A | 1 | 4.0 | 1.6 | 1.6 | 2 Apr 2025 |
| Glutathione | X N/A | 1 | 4.0 | 0.0 | 0.0 | 25 Apr 2025 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 1 | 4.0 | 1.4 | 1.4 | 20 Jun 2025 |
| LGD-4033 (Ligandrol) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 9 Jun 2025 |
| MOTS-C | X N/A | 1 | 4.0 | 2.5 | 2.5 | 6 May 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 1 | 4.0 | 0.1 | 0.1 | 3 Jul 2025 |
| NAD+ | X N/A | 1 | 4.0 | 1.9 | 1.9 | 13 Jun 2025 |
| P-2-P (phenyl-2-propanone / BMK) CAS 103-79-7 | X N/A | 1 | 4.0 | 0.5 | 0.5 | 24 Apr 2025 |
| PE 22-28 | X N/A | 1 | 4.0 | 0.8 | 0.8 | 13 Feb 2025 |
| PEG MGF | X N/A | 1 | 4.0 | 1.4 | 1.4 | 13 Jun 2025 |
| PTD-DBM | X N/A | 1 | 4.0 | 0.0 | 0.0 | 13 Jun 2025 |
| Retatrutide 30mg Pen Kit | X N/A | 1 | 4.0 | 0.9 | 0.9 | 9 Jun 2025 |
| Salbutamol | X N/A | 1 | 4.0 | 0.0 | 0.0 | 14 Jan 2025 |
| Selank | X N/A | 1 | 4.0 | 0.0 | 0.0 | 14 Jan 2025 |
| Superdrol | X N/A | 1 | 4.0 | 0.0 | 0.0 | 6 May 2025 |
| Test Enanthate | X N/A | 1 | 4.0 | 0.0 | 0.0 | 9 Jun 2025 |
| Thymosin Alpha-1 | X N/A | 1 | 4.0 | 1.5 | 1.5 | 2 Apr 2025 |
| Vitamin B12 10mg/ml | X N/A | 1 | 4.0 | 0.0 | 0.0 | 9 Jun 2025 |
| Vitamin D3 20000iu/ml | X N/A | 1 | 4.0 | 0.0 | 0.0 | 6 May 2025 |
Exhibit II
Evidence Log
35 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | MOTS-C | 4.3 C | 20mg | 24.1mg | +20.7% | 95.21% | sjno0v | Lab G | Community |
| 24 May 2026 | Thymosin Alpha-1 | 5.3 B | 50mg | 47.9mg | -4.1% | 95.05% | rmdznv | Lab C | Community |
| 24 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 5.3 B | 20mg | 22.1mg | +10.6% | 98.88% | mqq8ha | Lab B | Public |
| 24 May 2026 | Anadrol Oil | 4.8 C | 250mg/ml | 279.0mg/ml | +11.6% | 97.57% | a39k15 | Lab A | Public |
| 24 May 2026 | 5-amino-1MQ | 7.3 A | 20mg | 22.2mg | +10.8% | 99.46% | v9rm76 | Lab G | Community |
| 24 May 2026 | PE 22-28 | 4.4 C | 5mg | 5.5mg | +10.1% | 99.31% | yqsgjg | Lab D | Community |
| 23 May 2026 | Cardiogen | 4.0 C | 15mg | 17.3mg | +15.6% | 97.84% | a5n9qc | Lab G | Public |
| 23 May 2026 | Vitamin D3 20000iu/ml | 4.8 C | 250mg/ml | 259.3mg/ml | +3.7% | 98.47% | di3fzh | Lab D | Public |
| 23 May 2026 | 4-Piperidone monohydrate hydrochloride CAS 40064-34-4 | 5.1 B | 1g | 1.1g | +5.6% | 95.60% | u3bfze | Lab A | Public |
| 23 May 2026 | Clenbuterol | 5.3 B | 50mg | 44.4mg | -11.2% | 96.43% | lbfeix | Lab E | Public |
| 21 May 2026 | Selank | 4.9 C | 20mg | 20.2mg | +0.8% | 97.90% | j0cn5a | Lab A | Public |
| 21 May 2026 | Chonluten | 4.0 C | 50mg | 60.5mg | +21.0% | 96.05% | 3fwghg | Lab E | Public |
| 21 May 2026 | Vitamin B12 10mg/ml | 4.0 C | 300mg/ml | 262.7mg/ml | -12.4% | 96.78% | 7syk5a | Lab D | Public |
| 19 May 2026 | BAC Water | 4.0 C | 50mg | 45.3mg | -9.3% | 99.80% | n6x4wm | Lab F | Community |
| 19 May 2026 | DSIP | 4.0 C | 15mg | 16.2mg | +8.2% | 97.45% | km3afa | Lab F | Community |
| 19 May 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 4.0 C | 20mg | 24.1mg | +20.7% | 98.49% | i1frcw | Lab G | Public |
| 17 May 2026 | 4-Piperidone CAS 41661-47-6 | 4.9 C | 100g | 110.5g | +10.5% | 96.69% | 8lpthj | Lab G | Public |
| 17 May 2026 | NAD+ | 4.7 C | 10mg | 9.0mg | -10.0% | 98.52% | ndkwpg | Lab G | Community |
| 29 Jan 2026 | Test Enanthate | 4.0 C | 100mg/ml | 91.2mg/ml | -8.8% | 96.72% | fhwpvh | Lab E | Community |
| 19 Jan 2026 | PEG MGF | 4.3 C | 15mg | 13.0mg | -13.6% | 95.73% | fas1ul | Lab A | Public |
| 7 Jan 2026 | Superdrol | 5.8 B | 100mg | 103.0mg | +3.0% | 99.71% | ihkh9c | Lab D | Public |
| 29 Dec 2025 | EPO | 4.7 C | 2mg | 2.0mg | -2.1% | 97.81% | 83zf5y | Lab G | Community |
| 5 Dec 2025 | ACE-031 | 4.0 C | 20mg | 22.1mg | +10.5% | 99.30% | 2mg7s1 | Lab C | Public |
| 17 Nov 2025 | DEPAPD (diethyl phenylacetylpropanedioate) CAS 20320-59-6 | 4.0 C | 1g | 0.9g | -8.7% | 95.23% | tmq1sz | Lab D | Public |
| 17 Nov 2025 | GHRP-2 Acetate | 4.0 C | 15mg | 13.1mg | -12.5% | 98.70% | 10qprj | Lab D | Public |
| 17 Nov 2025 | Glutathione | 4.5 C | 50mg | 54.7mg | +9.5% | 97.14% | aujz6f | Lab A | Community |
| 14 Nov 2025 | BPC157 5mg + TB500 5mg Blend | 5.8 B | 50mg | 45.1mg | -9.9% | 99.61% | byejyr | Lab E | Public |
| 14 Nov 2025 | Dutasteride | 4.4 C | 100mg | 91.4mg | -8.6% | 96.68% | mjgx2y | Lab F | Community |
| 5 Nov 2025 | Botulinum toxin | 4.3 C | 10mg | 10.8mg | +7.9% | 96.93% | neg8cd | Lab D | Community |
| 4 Nov 2025 | Retatrutide 30mg Pen Kit | 4.0 C | 10mg | 8.6mg | -13.9% | 97.49% | 7qbqhj | Lab F | Public |
| 17 Oct 2025 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 4.0 C | 2mg | 2.0mg | +0.5% | 97.93% | 9bssfs | Lab E | Public |
| 17 Oct 2025 | PTD-DBM | 4.2 C | 2mg | 2.0mg | +0.5% | 95.98% | 8zyd9s | Lab G | Public |
| 17 Oct 2025 | Salbutamol | 5.1 B | 20mg | 23.5mg | +17.3% | 99.74% | 1gyqx5 | Lab F | Public |
| 9 Oct 2025 | P-2-P (phenyl-2-propanone / BMK) CAS 103-79-7 | 4.0 C | 500g | 616.8g | +23.4% | 97.02% | c4ry2x | Lab E | Community |
| 3 Oct 2025 | LGD-4033 (Ligandrol) | 5.1 B | 100mg | 114.4mg | +14.4% | 96.32% | mpz4e7 | Lab F | Community |
— END OF EVIDENCE LOG —